Tensive
PrivateLast Round
Series A
Jan 30, 2025
Total Funding Raised
$17.57M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Tensive operates in Healthcare & Life Sciences and is based in Milan. Its latest recorded funding round was a Series A round in January 2025.
Tensive is a medical device company developing bioresorbable polymeric scaffolds for breast reconstruction and tissue marking.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tensive Comparables
Compare Tensive with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BellaSeno | 86% | |
| Lattice Medical | 86% | |
| Healshape | 81% |
For institutional investors. Book with your work email.
Tensive Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 30, 2025 | ||||
| Grant | Dec 19, 2022 | ||||
| Seed | May 24, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Tensive Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant, Series A |
| CDP Venture Capital SGR | Series A |
| Panakès Partners | Series A |
| Invitalia Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 39, 7.8x the trailing average.
- Jul 13, 2026
Open roles increased to 21, 68% of headcount.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingSep 3, 2026
Tensive S.r.l. is set to receive a $23.2M convertible loan from the EIB on Sep 3rd '26 in Italy to fund REGENERA development, CE marking, manufacturing scale-up, and commercialization.
For institutional investors. Book with your work email.
Tensive Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Tensive's valuation, stock price, and market status.
Is Tensive a public or private company?
Tensive is a private company.
What is the current stock price of Tensive?
Tensive is a private company, so its shares have no public market price. Caplight tracks Tensive's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Tensive worth (valuation)?
Valuation information for Tensive is not publicly available.
Can I buy Tensive stock?
Tensive shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Tensive's last funding round?
Tensive's most recent funding round was Series A on January 30, 2025.
Who are the main investors in Tensive?
Key investors in Tensive include Panakès Partners.
Will Tensive IPO soon?
No public IPO plans have been announced for Tensive.
How can I track Tensive secondary market activity?
Caplight tracks bids, offers, and trades in Tensive's shares on secondary markets.